Ovarian Cancer Trial, Recruiting NCT07495397 Sponsor: The First Hospital of Jilin University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07495397
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old and have been diagnosed with stage III or IV ovarian cancer that has not yet been treated with any therapy
  • You have already completed surgery to remove as much of the tumor as possible (with no visible tumor or only a small amount remaining)
  • You are generally able to carry out daily activities with little or no limitation (as measured by a standard health scoring system)
  • Your doctors expect you to live for at least 12 weeks
  • Your organs (such as kidneys and liver) and bone marrow are functioning well enough to handle treatment
  • You are willing to provide a sample of your tumor tissue (either previously stored or freshly collected, though exceptions may apply — confirm with trial site)
  • You are able to understand what the trial involves and are willing to follow all the required visits and procedures

Who may not be able to join:

  • You have blood clotting problems, such as low platelet levels or abnormal clotting test results
  • You have a blood clot in the lung artery (pulmonary embolism) or in the large vein running through your abdomen (inferior vena cava thrombosis)
  • You have a tumor in your brain or spinal cord, or the cancer has spread there with active symptoms, or you have a history of epilepsy (some exceptions may apply — confirm with trial site)
  • You have had another type of cancer in the past 5 years, unless it was a minor, locally treated skin cancer or certain early-stage cancers that are considered fully cured
  • You have had a serious heart problem in the past 6 months, such as heart failure, a heart attack, dangerous irregular heartbeat, unstable chest pain, or blood pressure that cannot be controlled with medication
  • Your doctor judges that any other illness, physical finding, or test result makes it unsafe for you to take the study drug
  • You regularly take vitamin K by mouth (confirm with trial site)
  • You have tuberculosis that is currently untreated or still being treated (those fully cured after standard treatment may be eligible)
  • You have had a serious infection in the past 4 weeks, or an active infection in the past 2 weeks before starting the trial
  • You have HIV, active hepatitis B, hepatitis C, or syphilis
  • You are known to be allergic to any ingredient in the study drug
  • You have a known history of substance, alcohol, or drug misuse that could affect the trial results, or your doctor feels you are unlikely to follow the study requirements for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Hospital of Jilin University
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov